Literature DB >> 11884263

Interaction between blood pressure, lipoproteins, angiotensin, and vascular disease.

Aram V Chobanian1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884263     DOI: 10.1007/s11906-002-0030-5

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  28 in total

1.  Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia.

Authors:  W B Strawn; M C Chappell; R H Dean; S Kivlighn; C M Ferrario
Journal:  Circulation       Date:  2000-04-04       Impact factor: 29.690

Review 2.  Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition.

Authors:  R Dechend; A Fiebler; C Lindschau; H Bischoff; D Müller; J K Park; R Dietz; H Haller; F C Luft
Journal:  Am J Hypertens       Date:  2001-06       Impact factor: 2.689

3.  Angiotensin induces inflammatory activation of human vascular smooth muscle cells.

Authors:  R Kranzhöfer; J Schmidt; C A Pfeiffer; S Hagl; P Libby; W Kübler
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-07       Impact factor: 8.311

4.  Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men.

Authors:  G Nickenig; A T Bäumer; Y Temur; D Kebben; F Jockenhövel; M Böhm
Journal:  Circulation       Date:  1999-11-23       Impact factor: 29.690

5.  Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis.

Authors:  J D Luo; W W Zhang; G P Zhang; J X Guan; X Chen
Journal:  Clin Exp Pharmacol Physiol       Date:  1999-11       Impact factor: 2.557

6.  The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice.

Authors:  S Keidar; J Attias; J Smith; J L Breslow; T Hayek
Journal:  Biochem Biophys Res Commun       Date:  1997-07-30       Impact factor: 3.575

7.  Comparison of the effects of AT1 receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis.

Authors:  S Hope; P Brecher; A V Chobanian
Journal:  Am J Hypertens       Date:  1999-01       Impact factor: 2.689

8.  Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells.

Authors:  G Nickenig; A Sachinidis; F Michaelsen; M Böhm; S Seewald; H Vetter
Journal:  Circulation       Date:  1997-01-21       Impact factor: 29.690

9.  C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.

Authors:  P M Ridker; R J Glynn; C H Hennekens
Journal:  Circulation       Date:  1998-05-26       Impact factor: 29.690

Review 10.  National Education Programs Working Group report on the management of patients with hypertension and high blood cholesterol.

Authors: 
Journal:  Ann Intern Med       Date:  1991-02-01       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.